ArticleInternational journal of surgery. Oncology2017

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma.

Paul Toomey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.